FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089760978> ?p ?o ?g. }

• W3089760978 abstract "Background: There is limited data evaluating the prescription practices for antithrombotic therapy in patients with atrial fibrillation (AF) following elective percutaneous coronary intervention (PCI). Objective: This single-centre, single-operator, retrospective cohort study aimed to evaluate trends of antithrombotic treatment strategies in patients with AF undergoing elective PCI. Methods: Patients with AF who electively underwent PCI performed by a single interventionalist between April 2013 and May 2018 were identified. The primary outcome was the antithrombotic therapy at discharge assessed by chart review: triple (TAT; triple antithrombotic therapy) or dual (DAT; dual antithrombotic therapy) antithrombotic therapy and vitamin K antagonist (VKA) or non-vitamin k antagonist oral anticoagulant (NOAC), respectively. Secondary outcomes were rehospitalisation, death, bleeding requiring medical attention and stroke and were assessed via questionnaires and telephone contact at 3 months, 1 year and 3 years after discharge. Results: Of 6,135 screened patient visits, 259 met the inclusion criteria. Among these, 133 (51%) patients received NOAC- and 126 (49%) VKA-therapy. Compared with patients on NOAC therapy, patients treated with VKA had higher bleeding risk (mean HAS-BLED -Score; 2.3 vs. 2.0; p=0.02) and more co-morbidities (estimated glomerular filtration rate < 30ml/min, 11% vs. 4%; p=0.04; diabetes mellitus, 33% vs. 20%; p=0.03; history of previous PCI, 37% vs. 21%; p=0.006). TAT was prescribed more frequently if the prescription included VKA compared with NOAC (61% vs. 42%; p=0.002). Prescription of TAT and VKA decreased throughout the observed period (2013:100% vs. 2018: 6%; p<0.001 and 2013: 91% vs. 2018: 28%; p<0.001). The median follow up was 401 (IQR 171-1104) days post PCI with no significant differences in secondary outcomes between patients treated with NOAC compared with VKA. Conclusion: These observational data from a single centre registry show a paradigm chance in antithrombotic therapy of AF patients over the last 6 years, with a decrease of TAT- and VKA- prescription in favour of DAT with NOAC. Whether these observations are consistent with national or global trends should to be evaluated in further studies." @default.
• W3089760978 created "2020-10-08" @default.
• W3089760978 creator A5017098029 @default.
• W3089760978 creator A5030654513 @default.
• W3089760978 creator A5035510144 @default.
• W3089760978 creator A5040611700 @default.
• W3089760978 creator A5049318600 @default.
• W3089760978 creator A5061070510 @default.
• W3089760978 creator A5081120942 @default.
• W3089760978 date "2020-09-30" @default.
• W3089760978 modified "2023-10-16" @default.
• W3089760978 title "Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study" @default.
• W3089760978 cites W1914259002 @default.
• W3089760978 cites W1972142091 @default.
• W3089760978 cites W1976469399 @default.
• W3089760978 cites W2108659563 @default.
• W3089760978 cites W2122779695 @default.
• W3089760978 cites W2152584205 @default.
• W3089760978 cites W2152623033 @default.
• W3089760978 cites W2157718162 @default.
• W3089760978 cites W2165762371 @default.
• W3089760978 cites W2179039382 @default.
• W3089760978 cites W2418634846 @default.
• W3089760978 cites W2738278768 @default.
• W3089760978 cites W2949986921 @default.
• W3089760978 cites W2953934063 @default.
• W3089760978 cites W2957544571 @default.
• W3089760978 cites W2966878312 @default.
• W3089760978 doi "https://doi.org/10.3389/fmed.2020.00414" @default.
• W3089760978 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7561383" @default.
• W3089760978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33117822" @default.
• W3089760978 hasPublicationYear "2020" @default.
• W3089760978 type Work @default.
• W3089760978 sameAs 3089760978 @default.
• W3089760978 citedByCount "3" @default.
• W3089760978 countsByYear W30897609782021 @default.
• W3089760978 countsByYear W30897609782022 @default.
• W3089760978 countsByYear W30897609782023 @default.
• W3089760978 crossrefType "journal-article" @default.
• W3089760978 hasAuthorship W3089760978A5017098029 @default.
• W3089760978 hasAuthorship W3089760978A5030654513 @default.
• W3089760978 hasAuthorship W3089760978A5035510144 @default.
• W3089760978 hasAuthorship W3089760978A5040611700 @default.
• W3089760978 hasAuthorship W3089760978A5049318600 @default.
• W3089760978 hasAuthorship W3089760978A5061070510 @default.
• W3089760978 hasAuthorship W3089760978A5081120942 @default.
• W3089760978 hasBestOaLocation W30897609781 @default.
• W3089760978 hasConcept C126322002 @default.
• W3089760978 hasConcept C164705383 @default.
• W3089760978 hasConcept C167135981 @default.
• W3089760978 hasConcept C2776301958 @default.
• W3089760978 hasConcept C2776704044 @default.
• W3089760978 hasConcept C2777015399 @default.
• W3089760978 hasConcept C2778213512 @default.
• W3089760978 hasConcept C2779161974 @default.
• W3089760978 hasConcept C2780400711 @default.
• W3089760978 hasConcept C45393284 @default.
• W3089760978 hasConcept C500558357 @default.
• W3089760978 hasConcept C71924100 @default.
• W3089760978 hasConceptScore W3089760978C126322002 @default.
• W3089760978 hasConceptScore W3089760978C164705383 @default.
• W3089760978 hasConceptScore W3089760978C167135981 @default.
• W3089760978 hasConceptScore W3089760978C2776301958 @default.
• W3089760978 hasConceptScore W3089760978C2776704044 @default.
• W3089760978 hasConceptScore W3089760978C2777015399 @default.
• W3089760978 hasConceptScore W3089760978C2778213512 @default.
• W3089760978 hasConceptScore W3089760978C2779161974 @default.
• W3089760978 hasConceptScore W3089760978C2780400711 @default.
• W3089760978 hasConceptScore W3089760978C45393284 @default.
• W3089760978 hasConceptScore W3089760978C500558357 @default.
• W3089760978 hasConceptScore W3089760978C71924100 @default.
• W3089760978 hasLocation W30897609781 @default.
• W3089760978 hasLocation W30897609782 @default.
• W3089760978 hasLocation W30897609783 @default.
• W3089760978 hasOpenAccess W3089760978 @default.
• W3089760978 hasPrimaryLocation W30897609781 @default.
• W3089760978 hasRelatedWork W2145553842 @default.
• W3089760978 hasRelatedWork W2279559078 @default.
• W3089760978 hasRelatedWork W2522635874 @default.
• W3089760978 hasRelatedWork W2761498072 @default.
• W3089760978 hasRelatedWork W2786558405 @default.
• W3089760978 hasRelatedWork W2790591354 @default.
• W3089760978 hasRelatedWork W2793006228 @default.
• W3089760978 hasRelatedWork W2926662368 @default.
• W3089760978 hasRelatedWork W3130040365 @default.
• W3089760978 hasRelatedWork W4308927641 @default.
• W3089760978 hasVolume "7" @default.
• W3089760978 isParatext "false" @default.
• W3089760978 isRetracted "false" @default.
• W3089760978 magId "3089760978" @default.
• W3089760978 workType "article" @default.